^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

miR-638 Serves as a Biomarker of 5-Fluorouracil Sensitivity to Neoadjuvant Chemotherapy in Breast Cancer

Published date:
06/03/2022
Excerpt:
The MiniPDX™ model showed that MDA-MB-231 cells overexpressing miR-638 were more susceptible to 5-FU treatment in vivo....Overall, our findings uncovered a novel role for miR-638 in the regulation of 5-FU chemosensitivity in BC patients. miR-638 may serve as a potential biomarker for NAC response in patients with BC.
DOI:
https://doi.org/10.4048/jbc.2022.25.e24